博士毕业于四川大学华西基础医学与法医学院（2021.6），随后在四川大学华西基础医学与法医学院免疫教研室从事博士后研究（2021.9-2025.9）；现任四川大学华西基础医学与法医学院副教授（2025.9至今）。

以通讯或一作在Prog Neuropsychopharmacol Biol Psychiatry、J Psychiatry Neurosci、Int Immunopharmacol、Toxicology、 Archives of Toxicology等期刊发表论文19篇。主持国家自然科学基金青年项目和四川省自然科学基金青年项目；作为主研承担国家自然科学基金专项项目。

获第五届全国基础医学青年教师讲课大赛一等奖、第八届四川省高校青年教师教学竞赛二等奖、第九届四川大学教师教学创新竞赛一等奖等，同时荣获四川大学教学创新示范教师/课程，兼任四川省生物信息学学会智慧免疫分会第二届委员及四川省医学会微生物学与免疫学分会第二届青年学组委员。

主讲课程《医学免疫学》，参编教育部“101计划”核心教材《医学病原与免疫基础》数字教材；指导《全国大学生医学创新大赛暨“一带一路”国际竞赛》获国家级金奖2项、银奖2项、铜奖1项及省赛二等奖1项，并获“优秀指导教师”荣誉称号；指导国家级大创4项，省级大创3项；指导四川大学优秀本科毕业论文（一等奖）1篇；被评为四川大学拔尖创新人才培养优秀指导教师。

研究方向：

1. 神经精神疾病与肿瘤关键靶点的发现及药物干预研究

2. 蛋白翻译后修饰与免疫调控在疾病进展及药物干预中的作用机制

代表性论文：（近三年）

1. Lin K*, Wang P*, Li S, Ma C, Wen D, Wang X, Liao L. Immunometabolic reprogramming of central and peripheral immune cells in mental disorders: mechanisms and therapeutic implications. Front Immunol. 2026 Aug 4;17:1712425.

2. Huang D, Zhang H, Zhang Y, Chen C, Lin K, Wang X, Wang P*. Role of Aldo-Keto reductase family 1 member C in cancer progression: a special focus on the role of AKR1C1 in pancreatic cancer. Med Oncol. 2025 Dec 26;43(2):98.

3. Hu J*, Wang P*, Lin Y, Jiang Z, Zhang Y, Shi K, Wen D, Ma C, Liao L, Wang X. Increased peripheral CD4⁺ lymphocytes promote ketamine-induced abnormal behaviors in mice. Int Immunopharmacol. 2025 Aug 15;164:115337.

4. Wang P*, Lin K, Huang D, Jiang Z, Liao L, Wang X. The regulatory role of protein lactylation in various diseases: Special focus on the regulatory role of non-histone lactylation. Gene. 2025 May 27;963:149595. 

5.  Wang P*, Niu T, Huang D, Li Y, Jiang Z, Wang X, Liao L. Molecular mechanism of programmed cell death in drug-induced neuronal damage: A special focus on ketamine-induced neurotoxicity. Toxicology. 2025 May;513:154102.

6. Wang P*, Hu J, Chen C, Jiang Z, Zhang Y, Lin K, Liao L, Wang X. The immune regulatory mechanism of ketamine-induced psychiatric disorders: A new perspective on drug-induced psychiatric symptoms. Prog Neuropsychopharmacol Biol Psychiatry. 2025 Jan 10;136:111194.

7. Wang P*, Jiang L, Hu J, Jiang Z, Zhang Y, Chen C, Lin Y, Su M, Wang X, Liao L. The amino acid metabolism pathway of peripheral T lymphocytes and ketamine-induced schizophrenia-like phenotype. J Psychiatry Neurosci. 2024 Dec 3;49(6):E413-E426.

8. Wang P*, Chen C, Lin K, Zhang Y, Hu J, Zhu T, Wang X. The ‌BCL2-associated athanogene-3-Interferon-induced transmembrane protein 2 axis enhances pancreatic ductal adenocarcinoma growth via the Mitogen-activated protein kinase signaling pathway. Carcinogenesis. 2024 Dec 30;45(12):928-939. 

9.  Gao Y*, Shi K*, Wang P*, Liu X, Liu C, Luo L, Lin Y, Yang L, Yang R, Liao L. Identification of phase-I and phase-II metabolites and the metabolic pathway of the novel synthetic cannabinoid 5F-EDMB-PICA in vitro. Archives of Toxicology, 2024, 98(9):2879-2888.

10. Wang P, Pan Y, Zhang Y, Chen C, Hu J, Wang X. Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer. Med Oncol. 2024 Mar 12;41(4):85.

11.  Wang P, Min S, Chen C, Hu J, Wei D, Wang X. Phytohemagglutinin from Phaseolus vulgaris enhances the lung cancer cell chemotherapy sensitivity by changing cell membrane permeability. J Nat Med. 2024 Mar;78(2):355-369.